BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp reduced its position in Davita Inc (NYSE:DVA) by 20.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,777 shares of the company’s stock after selling 11,431 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Davita were worth $3,040,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of the stock. United Asset Strategies Inc. lifted its position in shares of Davita by 13.0% in the second quarter. United Asset Strategies Inc. now owns 6,405 shares of the company’s stock worth $445,000 after buying an additional 735 shares in the last quarter. Janney Montgomery Scott LLC lifted its position in shares of Davita by 4.5% in the second quarter. Janney Montgomery Scott LLC now owns 19,009 shares of the company’s stock worth $1,320,000 after buying an additional 811 shares in the last quarter. A.R.T. Advisors LLC lifted its position in shares of Davita by 0.6% in the first quarter. A.R.T. Advisors LLC now owns 165,500 shares of the company’s stock worth $10,913,000 after buying an additional 1,000 shares in the last quarter. Alps Advisors Inc. lifted its position in shares of Davita by 11.1% in the second quarter. Alps Advisors Inc. now owns 10,781 shares of the company’s stock worth $749,000 after buying an additional 1,080 shares in the last quarter. Finally, LS Investment Advisors LLC lifted its position in shares of Davita by 14.3% in the first quarter. LS Investment Advisors LLC now owns 10,198 shares of the company’s stock worth $672,000 after buying an additional 1,277 shares in the last quarter. Institutional investors own 87.80% of the company’s stock.
Shares of DVA stock opened at $67.24 on Friday. Davita Inc has a 1 year low of $52.51 and a 1 year high of $80.71. The company has a current ratio of 1.90, a quick ratio of 1.88 and a debt-to-equity ratio of 1.82. The company has a market cap of $11.20 billion, a price-to-earnings ratio of 20.53, a P/E/G ratio of 1.00 and a beta of 1.10.
Davita (NYSE:DVA) last issued its quarterly earnings data on Wednesday, August 1st. The company reported $1.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.08. Davita had a return on equity of 14.49% and a net margin of 4.30%. The business had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.88 billion. During the same period in the prior year, the business posted $0.92 earnings per share. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. equities research analysts anticipate that Davita Inc will post 4 earnings per share for the current fiscal year.
A number of equities research analysts recently commented on the company. Zacks Investment Research upgraded Davita from a “sell” rating to a “hold” rating in a research report on Tuesday, August 7th. William Blair reiterated a “buy” rating on shares of Davita in a research report on Wednesday, June 6th. Four equities research analysts have rated the stock with a hold rating, five have given a buy rating and two have issued a strong buy rating to the stock. Davita has a consensus rating of “Buy” and a consensus target price of $82.13.
Davita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Read More: NASDAQ Stock Market Explained
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.